Harvard Bioscience Inc
HBIOStock
$5.95+51.13%52W
Market Cap$27.29M
P/E—
Div yield—
Beta1.48
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-19.46%
Price vs S&P 500 (4W)0.75%
VGM Score54.84
Market Capitalization$27.29M
Earnings Surprise History
Q1 26-0.33est. -0.63
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.00
4.00
4.00
4.00
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HBIOHarvard Bioscience Inc | A | F | B | $5.95 |
| AAgilent Technologies Inc. | C | C | B | $136.10 |
| WATWaters Corp | D | C | B | $378.19 |
| ILMNIllumina Inc | D | D | A | $190.25 |
| MTDMettler-Toledo International | D | C | C | $1335.09 |
| RVTYRevvity, Inc. | C | D | B | $111.70 |
| BRKRBruker Corporation | D | D | B | $59.25 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $300.98 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $309.37 |
| AVTRAvantor, Inc. | B | F | B | $11.26 |
| TXG10x Genomics, Inc. Class A Common Stock | F | C | A | $44.48 |
About
Harvard Bioscience designs and manufactures specialized instruments and products for life sciences research, pharmaceutical discovery, and drug development. The company serves customers globally through direct and distribution channels, with brands including Harvard Apparatus, DSI, Buxco, Biochrom, and others. Most revenue is generated in the United States, though the company maintains operations across North America, Europe, and China.